The report "Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) – Global Forecast to 2026", is projected to reach USD 16.0 billion by 2026 from USD 12.2 billion in 2021, at a CAGR of 5.7% during the forecast period. A significant rise in the number of surgical procedures across the globe is driving the demand for biosurgery products. The increase in the number of elective surgeries can be attributed to the growing prevalence of obesity and other lifestyle diseases, the rising geriatric population, the increasing prevalence of orthopedic conditions, and the increasing incidence of spinal injuries and sports-related injuries. Biosurgery products are finding substantial application in severe trauma injuries, including traumatic brain injuries (TBIs), spinal cord injuries, spine fractures, collapsed lungs, and subarachnoid hemorrhage. Additionally, rising focus towards effective blood loss management during surgeries are also supporting the demand for biosurgery products such as hemostatic agents and surgical sealants and adhesives. Moreover, established market players are investing heavily into product R&D to gain competitive edge, which has resulted into an increasing availability of advanced biosurgery products in the market.